Related Experiment Videos
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma.
Anders Malmsten1, Xing-Wu Shao, Staffan Sjödahl
1Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Journal of Medical Virology
|May 20, 2005
Summary
A modified ExaVir Load test significantly enhances HIV-1 viral load detection sensitivity. This improved assay offers a more accurate and competitive method for quantifying human immunodeficiency virus type 1 RNA in patient plasma.
Area of Science:
- Virology
- Biochemistry
- Clinical Diagnostics
Background:
- Accurate human immunodeficiency virus type 1 (HIV-1) viral load monitoring is crucial for treatment efficacy.
- Existing viral load assays require continuous improvement in sensitivity and accuracy.
Purpose of the Study:
- To develop a more sensitive version of the ExaVir Load assay for HIV-1 viral load determination.
- To evaluate the performance and sensitivity of the modified ExaVir Load test.
Main Methods:
- Enhanced virion immobilization and washing steps using a non-lytic detergent.
- Optimized virion lysis conditions (salt, detergent, pH) and increased sample volume.
- Prolonged reverse transcriptase (RT) reaction time and colorimetric product detection.
Main Results:
- Achieved a tenfold increase in sensitivity compared to the original ExaVir Load assay.
- Demonstrated a detection limit of approximately 170 RNA copies/ml with colorimetric detection.
- Maintained strong correlation (r=0.90) with RNA PCR for viral load quantification.
Conclusions:
- The modified ExaVir Load test offers significantly improved sensitivity for HIV-1 viral load measurement.
- This enhanced assay presents a competitive alternative for clinical viral load determinations.
- Further sensitivity increases are possible with fluorimetric detection methods.